| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM196707272770401 |
| P698 | PubMed publication ID | 4166031 |
| P2093 | author name string | Schwartz RS | |
| Swanson MA | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 163-170 | |
| P577 | publication date | 1967-07-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Immunosuppressive therapy. The relation between clinical response and immunologic competence | |
| P478 | volume | 277 |
| Q47937198 | A comparative study of the action of cyclophosphamide and procarbazine on the antibody production in mice |
| Q71723750 | A comparative study of the effects of anti-tumour and immunosuppressive drugs on antibody-forming and erythropoietic cells |
| Q70710138 | A comparison of immunosuppressive and anti-inflammatory agents in the rat |
| Q41366787 | Abnormal lymphocyte function is secondary to drug-induced autoimmunity |
| Q69026672 | Actinic reticuloid in a black man: successful therapy with azathioprine |
| Q40385527 | Active specific immunotherapy against adenocarcinomas |
| Q40013211 | Anti-lymphocytic antibody and autoimmune disease: a review |
| Q70119236 | Antibody production in immunosuppressed recipients of renal allografts |
| Q69375076 | Antimetabolite therapy in the post-myocardial-infarction syndrome |
| Q37055522 | Antimyelin antibody in multiple sclerosis: no change during immunosuppression |
| Q39897265 | Antineoplastic and immunosuppressive drugs. II. Therapeutic uses |
| Q34476252 | Asymptomatic primary biliary cirrhosis |
| Q70117984 | Azathioprine for Crohn's disease |
| Q67264279 | Azathioprine in steroid-insensitive nephropathy |
| Q34621608 | Azathioprine metabolism in kidney transplant recipients |
| Q71783547 | Azathioprine treatment of ulcerative colitis, granulomatous colitis and regional enteritis |
| Q71540789 | Azathioprine: an adjunct to surgical therapy of granulomatous enteritis |
| Q35905122 | Basophils in tuberculin and "Jones-Mote" delayed reactions of humans |
| Q39738023 | Cancer after transplantation |
| Q47774206 | Canine early immunohistological responses to cardiac transplants |
| Q44587291 | Cell-mediated immunity in patients with leprosy |
| Q73803222 | Characterization of the impaired antipneumococcal polysacharide antibody production in immunosuppressed pediatric patients following cardiac transplantation |
| Q54495737 | Chlorambucil in the treatment of systemic lupus erythematosus |
| Q54447734 | Chromosomes in patients treated with Azathioprine |
| Q54189340 | Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. |
| Q67430617 | Collagen Profile in Rat Granulation Tissue after Cyclophosphamide Treatment |
| Q39536979 | Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis |
| Q35899906 | Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings |
| Q69950770 | Cytotoxic therapy in rheumatoid disease |
| Q71792582 | Delayed Hypersensitivity in Patients with Cancer |
| Q48792064 | Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression |
| Q67490021 | Disparity between clinical and immune responses in a controlled trial of azathioprine in rheumatoid arthritis |
| Q70620742 | Effect of Cyclophosphamide upon the Immune Response in Wegener's Granulomatosis |
| Q69372934 | Effect of therapeutic dosages of prednisone on human immunoglobulin G metabolism |
| Q40759594 | Examination of the effect of age and acquired immunity on the susceptibility of mice to infection with Aspergillus fumigatus |
| Q70676226 | Experience of immunosuppressive therapy of glomerular disease in adults |
| Q71815141 | Experiences with immunosuppressive therapy in childhood ulcerative colitis |
| Q33626928 | Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis |
| Q35935762 | Hodgkin's disease complicated by infection with Mycobacterium kansasii |
| Q43446850 | Host-tumor interactions during 5-fluorouracil therapy for prostatic carcinoma |
| Q24615872 | Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters |
| Q47796980 | IgM activity in human lymphotoxic antisera after renal transplantation |
| Q35909785 | Immune function in multiple myeloma: impaired responsiveness to keyhole limpet hemocyanin |
| Q33462327 | Immune response in patients with autoimmune thrombocytopenia and autoimmune haemolytic anaemia receiving azathioprine |
| Q49626139 | Immuno-Suppressive Drug Treatment of Keratitis Sicca, including an Example of Lichen Planus of the Conjunctiva |
| Q40741408 | Immunogenicities of haemocyanins from the giant African snail (Achatina fulica) and the keyhole limpet (Megathura crenulata) |
| Q70126345 | Immunoglobulin classes of antibodies produced in the primary and secondary responses in man |
| Q68350487 | Immunoglobulins in acute leukemia in children |
| Q40999293 | Immunology of renal transplantation |
| Q47932552 | Immunoregulation, oncogenic viruses, and malignant lymphomas |
| Q46198140 | Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis |
| Q39923325 | Immunosuppression — Agents, Procedures, Speculations and Prognosis |
| Q70425794 | Immunosuppressive Therapy for Ulcerative Colitis, Ileitis, and Granulomatous Colitis |
| Q66958029 | Immunosuppressive drugs: how do they act?* |
| Q71900780 | Immunosuppressive therapy |
| Q36830121 | Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review |
| Q40117551 | Immunosuppressive therapy for renal transplantation |
| Q37078919 | Immunosuppressive therapy in polymyositis |
| Q93792964 | Immunosuppressive therapy of pemphigus vulgaris. Preliminary results of azathioprine (Imuran) treatment) |
| Q39871859 | Immunotherapy in Inflammatory Bowel Disease |
| Q53880955 | Infectious risk factors in the immunosuppressed host |
| Q54475398 | Influence of azathioprine on humoral defence factors against Escherichia coli in germfree and monocontaminated rats |
| Q67535897 | Investigations on the influence of cyclophosphamide, gold sodium thiomalate and D-penicillamine on nystatin oedema and adjuvant arthritis |
| Q34570956 | Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies |
| Q33764096 | Keyhole limpet hemocyanin (KLH): a biomedical review |
| Q67444638 | Long-term azathioprine-corticosteroid therapy in lupus nephritis and idiopathic nephrotic syndrome |
| Q70121728 | Lymphocyte transformation in the Guillain-Barré syndrome |
| Q28243962 | Lymphomatoid granulomatosis |
| Q50242773 | Measurement of antibody-producing capacity in man. I. The normal response to flagellin from Salmonella adelaide |
| Q50237105 | Measurement of antibody-producing capacity in man. V. Immunoglobulin classes of antibodies to flagellin |
| Q50238131 | Measurement of antibody-producing capacity to flagellin in man. IV. Studies in autoimmune disease, allergy and after azathioprine treatment |
| Q71461596 | Mercaptopurine-dependent Remission of Nephrotic Syndrome |
| Q41635882 | Methotrexate use in miscellaneous inflammatory diseases |
| Q40277992 | Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients. |
| Q36439991 | Monomorphic post-transplant lymphoproliferative disorder of the tongue: case report and review of literature. |
| Q47911552 | Normal human IgG with antibody activity for keyhole limpet haemocyanin |
| Q53712136 | On corticosteroid and azathioprine treatment of glomerular renal diseases. A study of 90 cases, treated 1964-1969 |
| Q40591847 | Pharmacological and pathological responses of the human pulmonary circulation to drugs |
| Q44128743 | Primary Biliary Cirrhosis or Sarcoidosis — Or Both |
| Q34302895 | Problems with immunosuppressive agents in renal disease |
| Q41317813 | Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis |
| Q34052425 | Prolonged thoracic-duct drainage in rheumatoid arthritis and systemic lupus erythematosus |
| Q47743487 | Relative Importance of Cellular and Humoral Immunity in Human Renal Transplantation |
| Q35574179 | Response to cutaneous immunization with low-molecular-weight subunit keyhole limpet hemocyanin |
| Q69355642 | Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosu guidelines for dosage |
| Q53769990 | Serum IgG and Renal Transplantation |
| Q48008519 | Serum immunoglobulin levels in workers exposed to benzene, toluene and xylene. |
| Q36269299 | Studies on the anti-inflammatory action of 6-mercaptopurine |
| Q34635030 | Suppression of the immune response |
| Q33467433 | The Clinical Use of Immunosuppression |
| Q41220207 | The Effects of Azathioprine and 6 mp on Immunity |
| Q67312507 | The Effects of Cyclophosphamide and Azathioprine on Collagen in Skin and Granulation Tissue in Rats, and the Effects of Cyclophosphamide on Collagen in Human Skin |
| Q39906831 | The effect of amethopterin on the immune response |
| Q40857053 | The effect of azathioprine on cell-mediated immunity (CMI) to Candida albicans in Crohn's disease |
| Q40326474 | The effect of azathioprine on gammaglobulin synthesis in man |
| Q68617051 | The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation |
| Q70347820 | The human secondary immune response to Keyhole limpet haemocyanin |
| Q47952331 | The primary immune response to haemocyanin in patients with primary biliary cirrhosis |
| Q39867786 | The regulatory influence of activated T cells on B cell responses to antigen |
| Q86652654 | The treatment of disseminated vasculitis with methotrexate |
| Q33470895 | The use of azathioprine in refractory idiopathic thrombocytopenic purpura in children |
| Q41201521 | The use of therapeutic drug monitoring to optimise immunosuppressive therapy |
| Q70091409 | Treatment of dermatomyositis with methotrexate |
| Q67286603 | Treatment of eczema with cyclophosphamide and azathioprine* |
| Q74227032 | Tumour induction as a consequence of immunosuppression after renal transplantation |
| Q40679836 | Unusual fungal infections associated with immunologic hyporeactivity |
| Q44359564 | Wound Infections in Renal Transplant Patients |
| Q45117555 | Wound infections in renal transplant wounds: pathogenetic and prognostic factors |
| Q39922166 | “Immunosuppressive” treatment of “chronic glomerulonephritis” |
Search more.